Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours Β· Estimated delivery Aug 18 - Aug 23
Br J Pharmacol (2014) 171:72334
Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes
They inhibit the breakdown of glucagon-like peptide-1 (GLP-1) and increase the incretin effect in patients with type 2 diabetes
The neurochemical effects of GLP-1 medications on reward pathways appear to be dose-dependent and reversible
30 - 45 kg
Obesity is a chronic condition, characterised by excessive fat, which increases the risk of serious diseases such as type 2 diabetes
US$ 23.07
US$ 21.89
US$ 22.60
US$ 28.65
